I simply googled the title of his presentation: Bad Knees Might...

I simply googled the title of his presentation: Bad Knees Might Cause Broken Hearts

Yep PAR knows it has a future pipeline for sure here. Staggering to me is that there are phase 1/2 CVD drugs with market caps in the multi billions.

Your earlier point about potential take-up of a leading OA drug may not in fact need much direct marketing resonates loud and clear. Throw in the pipeline and its crazy to think how wide an application Zilosul may achieve once approved.

p.s. the best thing about our target markets is the self-interest in the biopharma that play in them. They won't simply let this potential mega blockbuster "gift horse" slide into nihility.